CAS 869748-10-7

Formula: C34H39N9O3

InChI: InChI=1S/C34H39N9O3/c1-21(44)41-14-16-42(17-15-41)24-9-11-25(12-10-24)43-33-30(32(35)36-20-37-33)31(39-43)23-8-13-26(29(19-23)46-3)38-34(45)28-18-22-6-4-5-7-27(22)40(28)2/h4-8,13,18-20,24-25H,9-12,14-17H2,1-3H3,(H,38,45)(H2,35,36,37)

InChI key: ZMNWFTYYYCSSTF-UHFFFAOYSA-N

SMILES: CC(=O)N1CCN(CC1)C2CCC(CC2)N3C4=NC=NC(=C4C(=N3)C5=CC(=C(C=C5)NC(=O)C6=CC7=CC=CC=C7N6C)OC)N

A-770041

CAS: 869748-10-7

A-770041

Formula: C₃₄H₃₉N₉O₃

Purity: 99.5%

Molecular weight: 621.73

Ref: 54-BUP20549

A-770041

CAS: 869748-10-7

A-770041 is an Lck inhibitor, YZ inhibits the production of IL-2 stimulated by concanavalin A in whole blood, and can prevent cardiac allograft rejection.

Formula: C₃₄H₃₉N₉O₃

Purity: 99.77% - 99.86%

Color and Shape: Solid

Molecular weight: 621.732

Ref: TM-T14074

A-770041

CAS: 869748-10-7

Formula: C₃₄H₃₉N₉O₃

Molecular weight: 621.732

Ref: IN-DA00GU0H

A-770041

Controlled Product

CAS: 869748-10-7

A-770041 is a molecule that inhibits the kinase domain of thymidylate synthase (TS). It has shown efficacy in animal studies, and is currently being evaluated for use in clinical trials. A-770041 has been shown to inhibit the growth of myeloid leukemia cells by inhibiting TS. It also inhibits the proliferation of T cells and other types of cancer cells. A-770041 is orally active, and it may be able to treat cancer by inhibiting TS.

Formula: C₃₄H₃₉N₉O₃

Purity: Min. 95%

Molecular weight: 621.73 g/mol

Ref: 3D-UJB74810